Thomas Sciascia

Affiliations

  • Chief Scientific Officer at Trevi Therapeutics Inc. (TRVI), 2024-08-21
  • Svp Clin Dev & Reg Aff & Cmo at Penwest Pharmaceuticals Co (PPCO), 2010-11-08
Insider Trading: Sales See All
Company Symbol Price Amount Relationship Remaining Holdings Date Form 4
TRVI $2.96 16,496 220,315 2024-08-19 Filing
TRVI $2.76 18,660 220,315 2024-08-16 Filing
TRVI $2.79 12,745 220,315 2024-08-15 Filing
TRVI $2.75 100 220,315 2024-08-14 Filing
TRVI $2.55 53,368 214,433 2024-05-29 Filing